Sano Genetics’ Post

Manifold.AI are joining AI in Pharma: Clinical Development as 2023 Summit supporters! Alexis Isabelle, Director of Business Solutions, shared with us why she is excited to join the AI in Pharma Summit next month. ➡ Join Alexis and other AI leaders on October 5th to hear more about the implementation of AI into clinical development and trials. Register your place today: #AI #ML #ClinicalDevelopment

BioSpace's Lori Ellis (Katz) writes: GenAI the youngest of the AI family, is evolving quickly. The global life sciences industry is attempting to evolve with it. However, as a keynote session at DIA's MASC with Stephen Pyke and Sherrine Eid, and moderated by Tamei Elliott suggests, taking a pause to understand AI risks and to prepare to comply with the European Commission's AI Act is what is needed. #ai #pharma #biospace https://hubs.li/Q02q5X9z0

Can an AI-Driven Preclinical Strategy Improve Clinical Success? Find out now by watching our new webinar on demand: https://hubs.la/Q024SVfJ0. #ArtificialIntelligence #AI #MachineLearning #TumorModels #CancerResearch #TranslationalScience #CertaintyisPriceless

Thank you Stephen Pyke, Sherrine Eid and Tamei Elliott for reminding the industry about the history of #AI, the potential risks, and offering suggestions on how to move forward as #GenAI evolves. Also thank you Stephen and Sherrine for giving more of your time to provide additional information. #biotech #pharma #DIA ##lifesciences

Shameer Khader, Ph.D, MPH from Sanofi at #Machinecon2023 shared invaluable insights on the role of AI in healthcare, emphasizing the potential of tailored treatments and the importance of a harmonious human-AI interaction. Khader's vision of a future where treatments are personalized using AI, while ensuring the core essence of human touch remains intact, is truly inspiring. It's a testament to the transformative potential of AI in enhancing patient care. #AIinHealthcare #PrecisionMedicine #Sanofi

New publication from The Alliance for Artificial Intelligence in Healthcare (AAIH) following the highly informative panel at #BIO2024 Read more about AI regulatory innovation in healthcare, SWOT analysis for AI and Regulatory Innovation. Well done Paul Howard, PhD Christopher Escobedo Hart Mida Pezeshkian, PhD Brandon Rice Alex Zhavoronkov

NEW PUBLICATION ALERT: AI and Regulatory Innovation in Healthcare: Shaping the Future At BIO 2024, The Alliance for Artificial Intelligence in Healthcare (AAIH) hosted a panel of members to discuss the challenges of AI and Regulatory Innovation. Expertly moderated by Paul Howard, PhD, the panel worked through a SWOT analysis on the current state of AI and regulation. The panel brought together diverse perspectives from Christopher Escobedo Hart, Mida Pezeshkian, PhD, Brandon Rice, and Alex Zhavoronkov. Read more about this new publication here: https://lnkd.in/e6kza8P3 #AAIH #AI #AIinhealthcare #innovation #aiinnovation #regulatoryinnovation

My colleague June Han has written this insightful and informative piece on how generative AI is impacting the field of protein design - worth a read!

🤖 Dive into the World of Artificial Intelligence at Oncode Accelerator! 🤖 Meet Gerard JP Van Westen van Westen, leading the charge in leveraging AI to drive the development of personalized therapies. In this video, he sheds light on how our AI platform is revolutionizing preclinical development. 👉 https://lnkd.in/eFrcy9JT ''By harnessing the power of AI, we're able to analyse vast datasets to identify, optimize, and predict the efficacy and safety of therapies.'' Gerard explains how these tools are crucial in placing patients at the heart of our research, paving the way for safer and more effective treatments. #AI #CancerResearch #OncodeAccelerator #Innovation

𝐃𝐚𝐭𝐚 𝐐𝐮𝐚𝐥𝐢𝐭𝐲: 𝐓𝐡𝐞 𝐂𝐨𝐫𝐧𝐞𝐫𝐬𝐭𝐨𝐧𝐞 𝐨𝐟 𝐄𝐟𝐟𝐞𝐜𝐭𝐢𝐯𝐞 𝐆𝐞𝐧𝐞𝐫𝐚𝐭𝐢𝐯𝐞 𝐀𝐈 𝐢𝐧 𝐏𝐡𝐚𝐫𝐦𝐚 Generative #AI has the potential to transform the drug discovery field. However, generative AI models need to be trained with quality datasets before it is productionized. Using an inadequately trained model in this context can result in inaccurate predictions, unviable outcomes, and significant project expenses. Dr. Abhishek Jha, in his keynote address, will discuss the importance of data quality in training the generative AI model and its role in enhancing the robustness and reliability of target prediction in the pharmaceutical industry. Join Abhishek's session, which is just a few days away, to learn more. Register for the virtual DataFAIR 2023 event using the link in the comments. #llm #drugdiscovery #datafair2023 #bioinformatics